ADAR1 Capital Management »

Io Biotech shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Io Biotech (IOBT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Io Biotech

Tip: Access up to 7 years of quarterly data

All positions including Io Biotech held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Io Biotech by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $15k 25k 0.61

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Io Biotech

Novo A/S
Millennium Management
Ikarian Capital
Beacon Pointe Advisors
Boothbay Fund Management
Dauntless Investment Group
Marshall Wace
Renaissance Technologies
Bridgeway Capital Management
Two Sigma Securities
UBS Group
Geode Capital Management
Hilton Capital Management
ADAR1 Capital Management
PKS Advisory Services

View all funds holding Io Biotech